Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Collaboration supports multiple discovery efforts, including vaccines
Subscribe To Our Newsletter & Stay Updated
